Delivery Order SPE2DB25D3006-SPE2DB25FXJCA
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication, with a ceiling value of $2,160.88 and a period of performance through April 2025. The contract is not set aside and appears to be part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00,...
This is a $5,414.15 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,105,734 units of Fluticasone-Salmeterol 115-21 12GM, a medication used to treat respiratory conditions. The contract has a ceiling value of $3,120.52 and a period of performance through May 2, 2025. The contract is not designated as a set-aside and is considered an...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone-salmeterol 115-21 12GM inhalation aerosol, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $9,236.69 and a period of performance through June 20, 2024. It is a firm-fixed-price contract, and there was...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $2,111.34 and a period of performance through April 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a $8,158.79 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of FLUTICASONE-SALMETEROL 230-21 12GM, a combination medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that Amerisourcebergen holds with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract has a ceiling value of $3,780.58 and a period of performance through April 11, 2025. This contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone-salmeterol 230-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract is a firm fixed-price delivery order with a ceiling value of $5,699.14 and a period of performance through May 8, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,714.04, is for the delivery of fluticasone-salmeterol 115-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract is a firm fixed-price delivery order, with a period of performance through May 8, 2025. This contract is not associated with a set-aside program and was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone-salmeterol 45-21 12GM, a combination medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price of $4,119.94 and a completion date of October 25, 2024. It is not designated as a set-aside contract, indicating open...